Cargando…
Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
OBJECTIVES: The aim of this study was to investigate the effects of citrulline (Cit) supplementation on inflammatory markers and liver histopathology in patients with non-alcoholic fatty liver disease (NAFLD). In this clinical trial, fifty NAFLD patients were assigned to receive 2 g/day Cit or place...
Autores principales: | Darabi, Zahra, Darand, Mina, Yari, Zahra, Hedayati, Mehdi, Faghihi, Amirhosein, Agah, Shahram, Hekmatdoost, Azita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376741/ https://www.ncbi.nlm.nih.gov/pubmed/30767788 http://dx.doi.org/10.1186/s13104-019-4130-6 |
Ejemplares similares
-
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
por: Saadati, Saeede, et al.
Publicado: (2019) -
Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
por: Rahimlou, Mehran, et al.
Publicado: (2016) -
Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Saadati, Saeede, et al.
Publicado: (2018) -
Dietary inflammatory index and risk of gallstone disease in Iranian women: a case-control study
por: Ghorbani, Moloud, et al.
Publicado: (2023) -
Comparison of cardiometabolic risk factors between obese and non-obese patients with nonalcoholic fatty liver disease
por: Yari, Zahra, et al.
Publicado: (2023)